Ankura vs. FTI vs. MERU for offer (RX)
Currently in a pickle, I've got offers from FTI, Ankura and Meru for their RX groups. Don't really know which one to pick. Would appreciate any help y'all can provide. In a nutshell, I'm looking for great culture, a diverse range of high-impact and interesting engagements, great exits down the line (corporate most likely), and more technical finance work rather than purely operational ( with the balance being around 50/50 for the operational / investor skills gained). I heard from multiple people that FTI has the best culture on the street, and is heavily involved in creditor side deals which I presume is the more technical side, but again, I'd like some second opinions. Don't really care about pay, all of them are more than my asking comp so I'm happy.
Also, I know that undergrad hiring has ramped up, and I'd like to ideally be in a lean team with a lot of experienced professionals and less juniors. I know UG / junior hiring won't likely reach remotely close to IB levels but would love some insight into future hiring trends.
Little bit of background, for context if needed: semi / target undergrad, was / am an associate in MF PE, and before that did a stint in HF ( not one of the mainstream ones like Citadel etc, but more under-the radar while being well known, like QVT, D.E Shaw, Schonfeld etc).
Edit: Wanted to pick some brains on this, but why is it so hard to break into RX consulting (atleast for me)? I applied when I was in HF but got dinged by basically every firm aside from a couple T4/5 firms. I thought the experience would make me competitive but I thought wrong I guess.
Edit x2: Comp for MERU, for the curious ppl (keep in mind this is variable given how specialized the firm is)
- Analyst: No clue, not sure if they even have analysts
- Associate: Base 150-200k, Bonus: 80 - 105%
- VP: Base 200-250k, Bonus: 100 - 130%
- Director: Base 300 - 500k , Bonus: 145 - 160% (this one is more variable because of the seniority level, based on what I was told)
Bump
Ankura had a big exodus to Huron due to toxic directors, but I heard the worst ones may have been forced out. Not sure tho. Decent MM firm, not what it used to be. MM roles are usually you + an MD flying to a client and getting everything done so you get a lot of exposure. Some resurgence on debtor stuff lately as middle markets die, but still a lot of creditor stuff.
FTI is a notch below Alix/A&M. You’ll get more big box work there, which tends to be a group of supporting staff who divide and conquer. FTI has a pyramid pay structure and wins fewer debtor mandates for its size, but has good flow. I’ve not heard consistently positive things about the culture.
Meru is a group of A&M/fti guys who broke off and are trying to run Alix/A&M’s playbook in middle markets. Their fees are very low because they’re pushing a success fee model in PEPI. RX feeds PEPI there. I would put their deal flow / quality a bit behind ankura, but I think Meru’s model is more modernized and they’re a relatively young firm with good growth. I would guess it’s more intense there vs ankura, but you’d probably learn a lot more under those guys and move up quicker.
Interesting, thanks for that!! My strategy for learning about culture was 1) ask current employees 2) ask former employees 3) ask people from other firms who have worked with the people at the target firm. Across all three metrics, I met very, very few people who had anything bad to say about the culture at FTI.
FYI - this is the culture at FTI's RX practice, not other practices. The thing with them, based on what I've heard is that culture varies wildly based on practice. RX has one of the (if not the) best cultures on the street, but there are some practices that are more moderate, and some that are downright atrocious.
Not sure if this'll matter to you, but the Deal's league tables just came out today, and FTI looks like it's got a pretty damn strong start in Chapter 11 restructurings (which IMO are the creme de la creme, as opposed to out of court). They're 2nd in out of court creditor engagements too, and top 5 in out of court debtor (debtor rankings for FTI historically rise in Q2-Q4 (to around top 3), as do creditor). This, combined with the fact that they basically led everything in FY '24 makes a pretty compelling case for them.
I really think that the FTI A&M / Alix argument is myopic and outdated in this day and age, especially since you're comparing debtor heavy to creditor heavy firms, talent is more mobile now than ever, and because FTI has a broader platform— stuff like legal, forensic, comms, regulatory—across many sectors. In contrast, A&M and Alix are still more concentrated around operational and performance improvement restructuring. Depending on the case, that breadth can be a major asset. Especially in large, litigious, or cross-border turnarounds, FTI’s multidisciplinary capabilities are a big deal. I'd argue that the real question now is fit for the mandate—not legacy status.
Damn, BRG has consistently been top 3-5 in both C&D mandates since like 2020. Idk if you have any insights but I thought they were super small. Are they alot larger a firm than I thought? Also, would you say A&M or Alix is a better place to start a career. Ik this is super random but just wanted some insight and figured you would be a good resource here.
FTI comp is substantially lower for a reason and I’m not sure how you can look at what Alix + A&M are working on vs FTI and conclude the quality is remotely the same - but big numbers make brain feel good I guess.
Furthermore, the issue is performance improvement’s success fee model is where the big bucks are these days and the top 2 firms use RX groups as feeders into PI. Alix and A&M absolutely dominate the most profitable niche.
Decided to create an account just to address this, based on my experience before retiring.
Here’s the deal—FTI’s strength isn’t hype, it’s strategy. The comp delta exists, sure, but pretending that automatically translates to quality is lazy thinking. FTI’s platform is built for scale and complexity—litigations, regulatory snarls, cross-border chaos. That’s real restructuring work, not just margin-chasing. Top performers still get paid, and the bench is deeper than people think. You don’t lead complex Chapter 11s year after year with B-tier talent.
Alix and A&M are machines in PI, no question, but calling that the “most profitable niche” only holds if you’re optimizing for short-term payouts, not long-term influence or mandate scope. They play a narrower game. FTI’s edge is in being indispensable when sh*t hits the fan across disciplines, not just ops.
To elaborate a little more, the “look at the mandates” argument cuts both ways. If you’re only looking at PI engagements and ignoring big, multi-stakeholder bankruptcies or cross-border messes, you’re missing half the game. FTI doesn’t need to win every $10M PI mandate—they're bagging billion-dollar turnarounds where legal, regulatory, comms, and ops all collide. That’s where they shine, and frankly, where the prestige actually lives.
Also—this idea that PI success fee models are the end-all? Shortsighted. Yes, they’re lucrative when they land, but they’re also episodic, volatile, and relationship-heavy to a fault. FTI’s model isn’t as sexy on paper, but it’s more sustainable. Steady flow of mandates, broader client base, and they’re on speed dial for the most sensitive situations. That’s not fluff—that’s resilience.
I know people are going to pull out the SVB and FTX engagements, but the thing is A&M’s work on FTX is ops-focused. SVB? A bank failure, with a playbook heavy on financial advisory and wind-down support. Important? Absolutely. But let’s not pretend that equates to handling sprawling multi-jurisdictional Ch.11s with litigation landmines, regulatory crossfire, and 10+ stakeholder groups. That’s FTI’s wheelhouse.
If you want to be a hammer, go A&M or Alix. But if you want to be the toolbox, FTI’s where the action is.
And to the big numbers point: Big numbers should make your brain feel something—if you understand what they mean. FTI's league table dominance isn't just fluff or volume for volume’s sake. It's a signal: clients, courts, and creditors trust them with the biggest, messiest cases. That kind of throughput sharpens teams, expands playbooks, and builds institutional knowledge that niche PI players just don’t get exposed to.
Acting like it's irrelevant is a cope. It’s easy to knock scale when your firm isn’t built for it. But in restructuring, volume at the top end of the market matters. It means you're winning mandates that demand real multidimensional problem-solving—not just margin-tweaking or cost cuts.
So yeah—big numbers do matter. Not because they make the “brain feel good,” but because they tell you who’s really in the room when it counts.
Feel free to DM me if you want to know more about FTI
Bump...
Dude, go with FTI.
I'm not OP lol, but yeah OP go with FTI
Out of the 3, FTI.
Unless you're dead set on exposure to multiple workstreams / management, then Ankura.
Great take.
Seconded
Slight situation update: got Province, might get Alix, does that change anything?
Gonna be honest, I'd personally still go FTI. Definitely FTI over Province. Between FTI and Alix, it comes down to your preference, can't go wrong with either, but I think you'll like the people at FTI...and the creditor side work more than the debtor side work
If I had to rank on these firms based purely on data, league tables, comp, exits, and wso:
A&M, Alix, FTI, BRG, Province, Ankura, Meru, M3 , Portage, Riveron. In that order.
BRG over Province is not accurate imo would switch the two.
Is M3 really that low? I thought they were big dogs that did the Sears bankruptcy, for example. Also, what's the scoop on Meru and why they're so high up? I've seen Riveron, Portage, etc. thrown around frequently as solid RX shops on WSO and have seen them as competitors for mandates, but they seem to be lower on your list vs Meru
Thank you all for the input, really appreciated it lol.
On another note, I've been getting a lot of questions about MERU and their comp, so here's what I know, for those who are curious.
Damn that's solid, especially the associate pay. Would love to see what comp is for MDs if you have that info, because I know they have that position
Iusto dignissimos debitis est quos ipsa vel at. Perspiciatis dolor nihil recusandae ducimus. Nobis autem fuga ipsa autem natus at atque.
Error officia voluptatem quasi hic veritatis amet qui maxime. Voluptatem a cupiditate unde voluptate mollitia consectetur quaerat quia. Vel excepturi sit et asperiores quis. Ex dignissimos pariatur velit tempora quia voluptas. Alias dolores impedit dolorem adipisci. Minus et sint doloribus corporis magnam et quisquam omnis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Est nam ea fuga nihil fuga excepturi quia. Illum qui dolor sint consequuntur blanditiis. Qui aut animi alias fuga aliquam aut aut.
Nihil ut harum accusantium adipisci ab. Suscipit velit perspiciatis incidunt voluptas. Aut veritatis natus itaque amet nulla occaecati. Cum perspiciatis ducimus in nihil.
Non harum quam autem amet nostrum eius. In quia qui nihil rem recusandae aut. Consequatur et quia doloremque eum distinctio. Esse ut corporis ratione.
Accusantium inventore omnis iure sit soluta. Autem quasi est voluptatibus et inventore quia. Culpa ex modi sed rerum quam expedita.